Pr. Agnès Buzyn - CML - Chronic Myeloid Leukemia
Pr. Agnès Buzyn. who specializes in hematology, cancer immunology and transplant, spent most of her career as a medical practitioner, professor and researcher at Paris-Descartes University (Paris-V) and at Necker Hospital in Paris .
Extract of Wikipedia
She was a member of the board of directors of the CML group Fi LMC.
ARTICLES IN ENGLISH
The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire
December 8, 2009, ASH2009
Low non-relapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: Report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
September 7, 2009, Biology of blood and Marrow Transplantation
Ex vivo characterization of multiepitopic tumor-specific CD8 T cells in patients with chronic myeloid leukemia: implications for vaccine development and adoptive …,
April 12, 2005, The Journal of Immunology
Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase
December 2003, Journal Blood
Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials
April 2003, PubMed
ARTICLES IN FRENCH
Agnès Buzyn : un médecin à l'écoute des patients pour diriger la HAS
March 7 2016, Pourquoi Docteur